Evidence map›Paper›PMID 25270736›Full record

ArticleBiostatistics (Oxford, England)2015

Testing for risk and protective trends in genetic analyses of HIV acquisition.

Janice M Mccarthy, Patrick R Shea, David B Goldstein, Andrew S Allen

Abstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Janice M MccarthyDepartment of Biostatistics and Bioinformatics, Duke University, Durham, NC 27710, USA.
Patrick R SheaCenter for Human Genome Variation, Duke University, Durham, NC 27710, USA.
David B GoldsteinCenter for Human Genome Variation, Duke University, Durham, NC 27710, USA.
Andrew S AllenDepartment of Biostatistics and Bioinformatics and Center for Human Genome Variation, Duke University, Durham, NC 27710, USA andrew.s.allen@duke.edu.

Funding

NEUROPATHOLOGY COREP30AG028377 · NIA · DUKE UNIVERSITY · PI WELSH-BOHMER, KATHLEEN ANNE · 2006 to 2011
$9.6M
Whole-genome sequencing for rare highly penetrant gene variants in schizophreniaRC2MH089915 · NIMH · DUKE UNIVERSITY · PI GOLDSTEIN, DAVID B. · 2009 to 2011
$4.6M
Full Human Genome Sequencing in ALSRC2NS070342 · NINDS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI BROWN, ROBERT H. · 2009 to 2010
$3.6M
Whole-genome sequencing in multiplex epilepsy familiesRC2NS070344 · NINDS · DUKE UNIVERSITY · PI GOLDSTEIN, DAVID B., OTTMAN, RUTH · 2009 to 2010
$2.0M
NIA NIH HHS P30 AG028377NIMH NIH HHS RC2MH089915NINDS NIH HHS 1RC2NS070342NINDS NIH HHS RC2NS070344PHS HHS UO1AIO67854
6 · The paper itself

Abstract

Host genetics studies of HIV-1 acquisition are critically important for the identification of new targets for drug and vaccine development. Analyses of such studies typically focus on pairwise comparisons of three different groups: HIV-1 positive individuals, HIV-1 high-risk seronegative individuals, and population controls. Because there is a clear expectation of how gene frequencies of risk or protective alleles would be ordered in the three groups, we are able to construct a statistical framework that offers a consistent increase in power over a wide-range of the magnitude of risk/protective effects. In this paper, we develop tests that constrain the alternative hypothesis to appropriately reflect risk or protective trends jointly across the three groups and show that they lead to a substantial increase in power over the naive pairwise approach. We develop both likelihood-ratio and score statistics that test for genetic effects across the three groups while constraining the alternative hypothesis to reflect biologically motivated trends of risk or protection. The asymptotic distribution of both statistics (likelihood ratio and score) is derived. We investigate the performance of our approach via extensive simulation studies using a biologically motivated model of HIV-1 acquisition, and find that our proposed approach leads to an increase in power of roughly 10-28%. We illustrate our approach with an analysis of the effect of the CCR5Δ32 mutation on HIV acquisition.

Indexed as

Data Interpretation, StatisticalGenetic Predisposition to DiseaseModels, TheoreticalHIV InfectionsHumansProtective FactorsReceptors, CCR5Risk FactorsCCR5 protein, humanReceptors, CCR5CCR5Constrained alternativeHigh-risk seronegativeHIV-1, Score statistic

Identifiers

PMID25270736
PMCPMC4441099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.